TECHNOLOGY COMMERCIALIZATION
SEARCH
Available Technologies:
Life Science
|
Physical Science
|
Research Tools
|
Software
Search Results - drug+delivery
10
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Co-polymer Stabilizers for Pressured Metered Dose Inhalers (pMDIs)
A series of novel co polymer surfactants with the general structure LAmEOnLAm were developed along with a Colloidal Probe Microscopy (CPM) method to optimize the surfactant composition using adhesion forces to improve stabilization of drug dispersions. This expands the range of biomolecules and micronized drug particles that can be formulated with pMDIs....
Published: 2/6/2014
|
Inventor(s):
Sandro Da Rocha
,
Libo Wu
Keywords(s):
Assay
,
Asthma
,
Compound
,
Device
,
Drug Delivery
,
Formulation
,
Instrumentation
,
Method
,
Pharmaceuticals
,
Process
,
Therapeutics
Category(s):
Chemicals
,
Drug Delivery
,
Pharmaceuticals
,
Instrumentation
,
Materials
New Immunotherapies for Cancer
Background Wayne State University researchers have developed a novel strategy to fight cancer and eradicate tumors through stimulation of the immune system. Curing cancer via the activation of patients’ immune system is considered an ideal strategy due to the potentially high potency and specificity of the human immune system to eradicate tumors....
Published: 3/31/2014
|
Inventor(s):
Zhongwu Guo
,
Qianli Wang
,
Shouchu Tang
Keywords(s):
Cancer Therapies
,
Drug Delivery
,
Pharmaceuticals
,
Therapeutics
,
Vaccines
Category(s):
Therapeutics
,
Life Science
,
Diseases
,
Oncology
Tumor Targeting by Small Molecule Therapeutics for a Proton-Coupled Folate Transporter (PCFT)
WSU and Duquesne University scientist have isolated a unique series of pyrrolopyrimidine antifolate analogs that show selective cytotoxicity toward solid tumors such as ovarian, prostate or breast cancer cells that express the low pH “proton-coupled folate transporter” (PCFT). The acidic pH optimum (pH 5.5-6.5) of PCFT makes it an ideal target...
Published: 3/31/2014
|
Inventor(s):
Larry Matherly
,
Aleem Gangjee
Keywords(s):
Analog or Analogue
,
Breast Cancer
,
Cancer Therapies
,
Drug Delivery
,
Ovarian Cancer
,
Prostate Cancer
Category(s):
Therapeutics
,
Life Science
,
Small molecule
,
Oncology
Visual Prostheses Based Upon Fiber-Optic Uncaging of Neurotransmitter Substances
Detailed Description A fiber optic cable may also be used to deliver light. The
drug delivery
system selectively delivers drugs to various types of neurological cells. In operation a solution of photoactivatable neuro-active drug is delivered to a pre-selected area in vivo and photoactivated in the solution at the pre-selected area to stimulate neurological...
Published: 3/31/2014
|
Inventor(s):
Patrick Mcallister
,
Raymond Iezzi
,
Gregory Auner
,
Gary Abrams
Keywords(s):
Drug Delivery
,
Neurological
,
Neuroscience
Category(s):
Medical
,
Life Science
,
Neurological disorders
,
Therapeutics
,
Drug Delivery
GlyB4 Fusion with Neuregulin Heparin-Targeting Domain to Block Neuregulin Signaling
We have harnessed this natural targeting ability of NRG by fusing the HBD of NRG to soluble HER4. This fusion protein retains high affinity heparin binding to heparin and to cells that express heparan sulfates resulting in a more potent NRG antagonist. In vivo, it is targeted to peripheral nerve segments where it blocks the activity of NRG as a Schwann...
Published: 2/6/2014
|
Inventor(s):
Jeffrey Loeb
,
Qunfang Lee
Keywords(s):
Anti-cancer
,
Biotechnology
,
Cancer risk
,
Cancer Therapies
,
Drug Delivery
,
Drug Target
,
Epilepsy
Category(s):
Life Science
,
Drug Delivery
,
Other
Dual action nanocarrier combining CXCR4 antagonist and polyplex gene delivery for treatment of metastatic cancer and other diseases
Novel bio-reducible polymer compositions which combine the ability to act as a CXCR4 antagonist and simultaneously provide enhanced gene delivery through the formation of inert nanocarrier polyplexes have been developed. As would be expected for biodegradable polymers, the cytotoxicity of these nanocarrier compositions are very low with measured IC50...
Published: 3/31/2014
|
Inventor(s):
David Oupicky
,
Jing Li
Keywords(s):
Cancer
,
Cancer Therapies
,
Compound
,
Drug Delivery
,
Drug Target
,
Formulation
,
Imaging
,
Nanomaterials
,
Pharmaceuticals
,
Therapeutics
Category(s):
Drug Delivery
,
Gene Therapy
,
Therapeutics
,
Life Science
,
Oncology
,
Nano-based
,
Metabolic disorders
,
Biologicals
Nanoparticle Method to Stabilize Suspension-Based pMDI HFA Formulations
Novel nanoparticle-based drug compositions and methods that improve and expand therapeutic
drug delivery
to the lungs through pressurized meter-dose inhalers (pMDIs). A large variety of approaches have been developed at WSU aimed at improving the aerosol characteristics and expanding the range of target species deliverable. These improved formulations...
Published: 2/6/2014
|
Inventor(s):
Sandro Da Rocha
,
Libo Wu
Keywords(s):
Asthma
,
Drug Delivery
,
Formulation
,
Nanomaterials
,
Pharmaceuticals
Category(s):
Drug Delivery
,
Life Science
,
Nano-based
,
Therapeutics
Improved pDMI Inhaler Formulations
Novel biodegradable, non-toxic nanoparticles that act as stabilizing excipients with a wide variety of suspension drug candidates including polar & non-polar drug particles, bio-macromolecules (proteins/peptides), gene therapies (DNA/siRNA) as well as amorphous and crystalline therapeutics have been developed which provide a platform for improving...
Published: 2/6/2014
|
Inventor(s):
Sandro Da Rocha
,
Libo Wu
Keywords(s):
Asthma
,
Drug Delivery
,
Formulation
,
Nanomaterials
,
Pharmaceuticals
,
Therapeutics
Category(s):
Drug Delivery
,
Life Science
,
Therapeutics
,
Nano-based
Drug-Dendrimer Nanoparticles for Targeted Treatment of Neuroinflammation
Highly effective dendrimer-drug based compositions and methods for treatment have been developed that target neuroinflammation both in the brain and the retina upon intravenous administration. The nanodevices overcome the blood-brain barrier (BBB) and deliver drugs to target cells (activated microglia and astrocytes) producing dramatic therapeutic improvements....
Published: 3/31/2014
|
Inventor(s):
Rangaramanujam Kannan
,
Raymond Iezzi
,
Bharath Rajaguru
,
Sujatha Kannan
Keywords(s):
Alzheimer's Disease
,
Compound
,
Disease
,
Drug Delivery
,
Imaging
,
Nanomaterials
,
Nanotechnology
,
Neural Probes
,
Neuro-disorders
,
Parkinson's
,
Pharmaceuticals
,
Therapeutics
Category(s):
Drug Delivery
,
Therapeutics
,
Diseases
,
Life Science
,
Nano-based
,
Vision
,
Imaging
,
Neurological disorders
,
Dendrimer
Novel Method of Making 3-Dimensional Neural Probes
WSU researchers have developed a unique design for neural probes with both electrical and chemical interfaces, via arrays metal electrodes and micro-channels that can be easily manufactured and folded in 3D arrays. The fabrication process is post-CMOS compatible allowing simple, reliable and cost effective construction of the all the components. Methods...
Published: 2/6/2014
|
Inventor(s):
Yong Xu
,
Yuefa Li
Keywords(s):
Biotechnology
,
Drug Delivery
,
Epilepsy
,
Microchannels
,
Neural Probes
,
Neuroscience
Category(s):
Drug Delivery
,
Life Science
,
Medical Devices
,
Other
,
MEMS
,
Microfluidics
,
Physical Sciences
,
Sensors